About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

More Use of Statins is Recommended to Prevent Cardiovascular Events

by Hannah Joy on January 2, 2018 at 4:24 PM
Font : A-A+

More Use of Statins is Recommended to Prevent Cardiovascular Events

Guidelines that recommend more use of statins for primary prevention of atherosclerotic cardiovascular disease (ASCVD) can prevent more events than guidelines that recommend less use of statins, reveals a new study.

The findings are published in Annals of Internal Medicine.

Advertisement


Researchers from Copenhagen University Hospital compared the utility of five guidelines published since 2013 for the primary prevention of ASCVD. Despite being founded on the same evidence, the five guidelines have substantial differences, including in the recommended prediction model for ASCVD and in the risk threshold and low-density lipoprotein cholesterol (LDL-C) cut point for assignment of statin use.

Researchers conducted an observational study of actual ASCVD events during 10 years followed by a modeling study to estimate the effectiveness of different guidelines in a contemporary cohort of 45,750 persons aged 40 to 75 years who did not use statins and did not have ASCVD at baseline between 2003 and 2009.
Advertisement

The study found that the percentage of participants eligible for statins was 44 percent by the Canadian Cardiovascular Society (CCS) guideline, 42 percent by the American College of Cardiology/American Heart Association (ACC/AHA), 40 percent by the National Institute for Health and Care Excellence (NICE), 31 percent by the U.S. Preventive Services Task Force (USPSTF), and 15 percent by ESC/EAS.

The estimated percentage of ASCVD events that could have been prevented by using statins for 10 years was 34 percent for CCS, 34 percent for ACC/AHA, 32 percent for NICE, 27 percent for USPSTF, and 13 percent for the European Society of Cardiology/European Atherosclerosis Society (ESC/EAS).

Guidelines from the ACC/AHA, CCS, or NICE should be followed rather than those from the USPSTF and ESC/EAS, the researchers concluded.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
Toothache
World AIDS Day 2021 - End Inequalities, End AIDS
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Cholesterol Cholesterol - The Enigma Chemical Statins 

Recommended Reading
Statin Users Most Likely to Experience Muscle Pain
Statins are a common group of drugs prescribed by doctors to treat cholesterol. However, they come ....
Statin Use Prior Cardiac Arrest Improves Survival Rate
Study shows that statin users are likely to survive longer after a cardiac arrest compares to ......
No Link Between Intracerebral Hemorrhage and Statin Use Among Patients With Prior Stroke
Study reveals use of cholesterol-lowering statin medications is not associated with subsequent ......
USPSTF Recommendations can Lead to Fewer Number of Statin Users
The U.S. Preventive Services Task Force (USPSTF) recommendations on statin therapy can result in ......
Cholesterol
Cholesterol is produced by the body (liver) and is essential for normal body functioning....
Cholesterol - The Enigma Chemical
The word 'Cholesterol' rings danger bells as soon as it is mentioned. This important chemical is im...
Statins
Statins are new wonder drugs that are proving to be efficacious, not merely in relieving symptoms bu...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use